Happy New Year 2025
1 January 2025The SORGEM Evaluation team wishes you an exceptional year 2025.
MammoRisk® is the first solution developed by Predilife dedicated to stratified breast cancer screening. This software uses a scoring tool…
The CNEJEF (Compagnie Nationale des Experts de Justice en Finance), chaired by Claire Karsenti, Partner at Sorgem Evaluation, organised its…
Blanche Feauveaux, Partner at SORGEM Evaluation, spoke on September 20th, 2024, to students in the Master 2 Corporate Finance program…
Claire Karsenti, Partner at Sorgem Evaluation, co-hosted the morning session on September 17, 2024, alongside Elisabeth Avril, Specialized Assistant at…
The public tender offer (OPA) aims to strengthen the founders’ stake in the company’s capital while welcoming a new long-term…
As announced in the press release dated 30 June 2024, the Board of Directors of ATOS has appointed SORGEM Evaluation,…
Following the acquisition by GROUPE ENTREPRENDRE, a wholly owned subsidiary of DANAE Group, of a controlling stake from Mr. Robert…
Sorgem Evaluation acted as financial expert in an international arbitration. A company in the banking sector called on Sorgem Evluation…
On April 12, 2024, Blanche Feauveaux, Partner at Sorgem Evaluation and financial expert, spoke alongside Fanny Ducloy, real estate expert,…
On March 27 and 28, 2024, Blanche Feauveaux, Partner at Sorgem Evaluation, led a training course on company valuation at…